REQUEST A DEMO
Total
USD $0.00
Search more companies

Hana Pharm Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Scientific Research and Development Services
Full name: Hana Pharm Co.,Ltd. Profile Updated: August 07, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Hana Pharm Co.,Ltd. is an enterprise in South Korea, with the main office in Hwaseong. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on January 19, 1978. It currently has a total number of 708 (2025) employees. From the latest financial highlights, Hana Pharm Co.,Ltd. reported a net sales revenue increase of 8.32% in Q12026. A growth of 12.61% was recorded in its total assets. In, 2026, the company’s net profit margin increased by 8.69%.

Headquarters
13-39, Jeyakdanji-Ro, Hyangnam-Eup, Hwaseong-Si, Gyeonggi-Do
Hwaseong; Gyeonggi;

Contact Details: Purchase the Hana Pharm Co.,Ltd. report to view the information.

Website: http://www.hanaph.co.kr

Basic Information
Total Employees:
Purchase the Hana Pharm Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Hana Pharm Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Hana Pharm Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Hana Pharm Co.,Ltd. report to view the information.
Incorporation Date:
January 19, 1978
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
25.2%
Purchase this report to view the information.
11.4%
Purchase this report to view the information.
11%
Subsidiaries
하나제약(주)
Company Performance
Financial values in the chart are available after Hana Pharm Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
8.32%
Total Operating Revenue
19.24%
Operating Profit
149.88%
EBITDA
82.22%
Net Profit/Loss for the Period
135.92%
Total Assets
12.61%
Total Equity
5.01%
Operating Profit Margin
12.45%
Net Profit Margin
8.69%
Return on Equity (ROE)
1.74%
Debt / Equity
11.21%
Quick Ratio
-0.33%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?